Résumés
Résumé
Cet article porte sur une recension des écrits sur l’évaluation économique des traitements éprouvés cognitivo-comportementaux et pharmacologiques des troubles anxieux. La recherche des articles pertinents s’échelonne de 1980 à 2008, à partir des bases de données électroniques du milieu médical et psychologique. Sept études sont recensées et portent sur le trouble panique, le trouble d’anxiété généralisée, la phobie spécifique et la phobie sociale. Les traitements pharmacologiques et la psychothérapie cognitive-comportementale présentent un rapport coûts-efficacité avantageux, particulièrement lorsque comparés aux soins usuels. Les auteurs concluent que malgré le besoin de renforcer l’état des connaissances sur le rapport coûts-efficacité des interventions, il semble avantageux pour la société d’accroître l’accès aux traitements éprouvés des troubles anxieux.
Abstract
This article reviews the literature on economic studies of evidence-based cognitive-behavioral treatment and pharmacotherapy for anxiety disorders. Articles were identified through electronic search of medical and psychological databases between 1980 and 2008. Seven studies were identified and included panic disorder, generalized anxiety disorder, specific phobia and social phobia. Results show that evidence-based cognitive-behavior therapy and pharmacotherapy are cost-effective, usually more than usual care. Although the evidence base needs to be strengthened, it appears beneficial in increasing access to evidence-based treatments for anxiety disorders from a societal perspective.
Resumen
Este artículo trata de una recensión de los textos de la evaluación económica de los tratamientos cognitivo-comportamentales y farmacológicos de los trastornos de ansiedad probados. La búsqueda de los artículos pertinentes se extiende de 1980 a 2008, a partir de las bases de datos electrónicas del medio médico y psicológico. Se recensan siete estudios que tratan acerca del trastorno de pánico, el trastorno de ansiedad generalizada, la fobia específica y la fobia social. Los tratamientos farmacológicos y la psicoterapia cognitivo-comportamental presentan una relación costo-eficacidad ventajosa, particularmente al compararlos con los cuidados usuales. Los autores concluyen que a pesar de la necesidad de aumentar el estado de los conocimientos sobre la relación costo-eficacidad de las intervenciones, parece ventajoso para la sociedad incrementar el acceso a los tratamientos probados de los trastornos de ansiedad.
Resumo
Este artigo é uma recensão da literatura sobre a avaliação econômica dos tratamentos dos transtornos de ansiedade cognitivo-comportamentais e farmacológicos reconhecidos. A pesquisa dos artigos pertinentes se estende de 1980 a 2008, a partir dos bancos de dados eletrônicos do meio médico e psicológico. Sete estudos são recenseados e tratam sobre o transtorno do pânico, o transtorno de ansiedade generalizada, a fobia específica e a fobia social. Os tratamentos farmacológicos e a psicoterapia cognitiva-comportamental apresentam uma relação custo-eficácia vantajosa, particularmente quando comparados às atenções usuais. Os autores concluem que, apesar da necessidade de reforçar o estado dos conhecimentos sobre a relação custo-eficácia, seria vantajoso para a sociedade aumentar o acesso aos tratamentos dos transtornos de ansiedade reconhecidos.
Veuillez télécharger l’article en PDF pour le lire.
Télécharger
Parties annexes
Bibliographie
- Agence canadienne des médicaments et des technologies de la santé, 2006, Lignes directrices de l’évaluation économique des technologies de la santé au Canada, 3e édition, Ottawa.
- Association des psychiatres du Canada, 2006, Guide de pratique clinique : Traitement des troubles anxieux, La Revue canadienne de psychiatrie, 51, supplément 2, 1s-97s.
- Baldwin, D. S., Anderson, I. M, Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R. T, Den Boer, J. A., Fineberg, N.A., Knapp, M., Scott, J., Wittchen, H. U, 2005, Evidence-based guidelines for the pharmacological treatment of anxiety disorders : recommendations from the British Association for psychopharmacology, Journal of Psychopharmacology, 19, 6, 567-596.
- Barlow, D. H., Gorman, J. M., Shear, M. K., Woods, S. W., 2000, Cognitive-behavioral therapy, imipramine, or their combination for panic disorder. A randomized controlled trial, JAMA, 283, 19, 2529-2536.
- Bower, P., Richards, D., Lovell, K., 2001, The clinical and cost-effectiveness of self-help treatments for anxiety and depressive disorders in primary care : a systematic review, British Journal of General Practice, 51, 471, 838-845.
- Briggs, A. H., 2001, A Bayesian approach to stochastic cost-effectiveness analysis, International Journal of Technology Assessment in Health Care, 17, 1, 69-82.
- Cavanagh, K., Shapiro, D. A., 2004, Computer treatment for common mental health problems, Journal of Clinical Psychology, 60, 3, 239-251.
- Cochrane Effective Practice and Organisation of Care Review Group (EPOC), 2002, http://www.epoc.cochrane.org/en/handsearchers.html, consulté le 24 septembre 2008.
- Drummond, M. F., O’Brien, B., Stoddart, G. L., Torrance, G. W., 1997, Methods for the Economic Evaluation of Health Care Programmes, 2nd edition, Oxford University Press, New York.
- Duhoux, A., Fournier, L., Nguyen, C., Roberge, P., Beveridge, R., sous presse, Guideline concordance of treatment for depressive disorders in Canada, Social Psychiatry and Psychiatric Epidemiology.
- Greenberg, P. E., Sisitsky, T., Kessler, R. C., Finkelstein, S. N., Berndt, E. R., Davidson, J. R., Ballenger, J. C., Fyer, A. J., 1999, The economic burden of anxiety disorders in the 1990s, The Journal of Clinical Psychiatry, 60, 7, 427-435.
- Hoch, J. S., Smith, M. W., 2006, A guide to economic evaluation : methods for cost-effectiveness analysis of person-level data, Journal of Traumatic Stress, 19, 6, 787-797.
- Issakidis, C., Andrews, G., 2002, Service utilisation for anxiety in an Australian community sample, Social Psychiatry And Psychiatric Epidemiology, 37, 4, 153-163.
- Issakidis, C., Sanderson, K., Corry, J., Andrews, G., Lapsley, H., 2004, Modelling the population cost-effectiveness of current and evidence-based optimal treatment for anxiety disorders, Psychological Medicine, 34, 1, 19-35.
- Kaltenthaler, E., Shackley, P., Stevens, K., Beverley, C., Parry, G., Chilcott, J., 2002, A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety, Health Technology Assessment, 6, 22, 1-89.
- Katon, W., Russo, J., Sherbourne, C., Stein, M. B., Craske, M., Fan, M.-Y., Roy-Byrne, P., 2006, Incremental cost-effectiveness of a collaborative care intervention for panic disorder, Psychological Medicine, 36, 3, 353-363.
- Leon, A. C., Portera, L., Weissman, M. M., 1995, The social costs of anxiety disorders, British Journal of Psychiatry, Supplement, 27, 19-22.
- Marchand, A., Germain, V., Reinharz, D., Mainguy, N., Landry, P., 2004, Analyse des coûts et de l’efficacité d’une psychothérapie pour le Trouble panique avec agoraphobie versus un traitement combinant la pharmacothérapie et la psychothérapie, Santé mentale au Québec, 29, 2, 201-220.
- McCrone, P., Knapp, M., Proudfoot, J., Ryden, C., Cavanagh, K., Shapiro, D.A., Ilson, S., Gray, J. A., Goldberg, D., Mann, A., Marks, I., Everitt, B., Tylee, A., 2004, Cost-effectiveness of computerised cognitive-behavioural therapy for anxiety and depression in primary care : randomised controlled trial, British Journal of Psychiatry, 185, 55-62.
- McHugh, R.K., Otto, M.W., Barlow, D.H., Gorman, J.M., Shear, M.K., Woods, S.W., 2007, Cost-efficacy of individual and combined treatments for panic disorder, Journal Of Clinical Psychiatry, 68, 7, 1038-1044.
- Ministère de la santé et des services sociaux (MSSS), 2005, Plan d’action en santé mentale 2005-2010 : La force des liens, Québec.
- Murray, C. J. L., Evans, D. B., Acharya, A., Baltussen, R. M., 2000, Development of WHO guidelines on generalized cost-effectiveness analysis, Health Economics, 9, 3, 235-251.
- Netten, A., Curtis, l., 2000, Units Costs of Health and Social Care, Canterbury, PSSRU.
- Organisation mondiale de la santé, Rapport sur la santé dans le monde 2001, La santé mentale, nouvelle conception, nouveaux espoirs, Organisation mondiale de la santé.
- Otto, M. W., Pollack, M. H., Maki, K. M., 2000, Empirically-supported treatments for panic disorder : costs, benefits, and stepped care, Journal of Consulting and Clinical Psychology, 68, 4, 556-563.
- Roberge, P. Marchand, A., Reinharz, D., Savard, P., 2008, Cognitive-behavioral treatment for panic disorder with agoraphobia., A randomized controlled trial and cost-effectiveness analysis, Behavior Modification, 32, 3, 333-351.
- Roy, S., Madhavan, S. S., 2008, Making a case for employing a societal perspective in the evaluation of Medicaid prescription drug interventions, Pharmacoeconomics, 26, 4, 281-296.
- Roy-Byrne, P. P., Wagner, A. W., Schraufnagel, T. J., 2005, Understanding and treating panic disorder in the primary care setting, Journal Of Clinical Psychiatry, 66, Suppl 4, 16-22.
- Somers, J. M., Goldner, E. M., Waraich, P., Hsu, L., 2006, Prevalence and incidence studies of anxiety disorders : a systematic review of the literature, Canadian Journal of Psychiatry, 51, 2, 100-113.
- Stant, A. D., Ten Vergert, E. M., den Boer, P. C. A. M., Wiersma, D., 2008, Cost-effectiveness of cognitive self-therapy in patients with depression and anxiety disorders, Acta Psychiatrica Scandinavica, 117, 1, 57-66.
- Stein, M. B., Sherbourne, C. D., Craske, M. G., Means-Christensen, A., Bystritsky, A., Katon, W., Sullivan, G., Roy-Byrne, P. P., 2004, Quality of care for primary care patients with anxiety disorders, American Journal of Psychiatry, 161, 12, 2230-2237.
- van Roijen, L.H., van Straten, A., Al, M., Rutten, F., Donker, M., 2006, Cost-utility of brief psychological treatment for depression and anxiety, British Journal of Psychiatry, 188, 323-329.
- Wang, P. S., Berglund, P., Kessler, R. C., 2000, Recent care of common mental disorders in the United States : prevalence and conformance with evidence-based recommendations, Journal of General Internal Medicine, 15, 5, 284-292.
- Young, A. S., Klap, R., Sherbourne, C. D., Wells, K. B., 2001, The quality of care for depressive and anxiety disorders in the United States, Archives of General Psychiatry, 58, 1, 55-61.